Interferon-γ and interferon-γ receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting

Atherosclerosis

Volumn 182, Issue 1, 2005, Pages 145-151

  Tiroch, K ^a   Von Beckerath, N ^a   Koch, W ^a   Lengdobler, J ^a   Joost, A ^a   Schomig A ^a   Kastrati, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Genetics; Interferon ; Receptor; Restenosis

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; RECEPTOR SUBUNIT;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY STENT; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; HYPOTHESIS; IMPLANTATION; INCIDENCE; INTIMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTENOSIS; UPREGULATION;

AGED; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; INTERFERON TYPE II; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; RECEPTORS, INTERFERON; STENTS;

EID: 23944513266     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.02.003     Document Type: Article

References (25)

1. A. Farb, G. Sangiorgi, and A.J. Carter Pathology of acute and chronic coronary stenting in humans Circulation 99 1999 44 52
2. A. Farb, D.K. Weber, F.D. Kolodgie, A.P. Burke, and R. Virmani Morphological predictors of restenosis after coronary stenting in humans Circulation 105 2002 2974 2980
3. F.G. Welt, and C. Rogers Inflammation and restenosis in the stent era Arterioscler Thromb Vasc Biol 22 2002 1769 1776
4. A. Billiau Interferon-gamma: biology and role in pathogenesis Adv Immunol 62 1996 61 130
5. D. Zohlnhöfer, T. Richter, and F. Neumann Transcriptome analysis reveals a role of interferon-gamma in human neointima formation Mol Cell 7 2001 1059 1069
6. S. Gupta, A.M. Pablo, X. Jiang, N. Wang, A.R. Tall, and C. Schindler IFN-gamma potentiates atherosclerosis in ApoE knock-out mice J Clin Invest 99 1997 2752 2761
7. G. Tellides, D.A. Tereb, and N.C. Kirkiles-Smith Interferon-gamma elicits arteriosclerosis in the absence of leukocytes Nature 403 2000 207 211
8. V. Pravica, C. Perrey, A. Stevens, J.H. Lee, and I.V. Hutchinson A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production Hum Immunol 61 2000 863 866
9. V. Pravica, A. Asderakis, C. Perrey, A. Hajeer, P.J. Sinnott, and I.V. Hutchinson In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene Eur J Immunogenet 26 1999 1 3
10. T. Thye, G.D. Burchard, M. Nilius, B. Müller-Myhsok, and R.D. Horstmann Genomewide linkage analysis identifies polymorphism in the human interferon-γ receptor affecting Helicobacter pylori infection Am J Hum Genet 72 2003 448 453
11. H. Nakashima, H. Inoue, and M. Akahoshi The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus FEBS Lett 453 1999 187 190
12. J. Reboul, K. Gardiner, D. Monneron, G. Uze, and G. Lutfalla Comparative genomic analysis of the interferon/interleukin-10 receptor gene cluster Genome Res 9 1999 242 250
13. A. Schömig, A. Kastrati, and H. Mudra Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure Circulation 90 1994 2716 2724
14. A. Schömig, F.J. Neumann, and A. Kastrati A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents N Engl J Med 334 1996 1084 1089
15. World Health Organisation Study Group Diabetes mellitus WHO Tech Rep Ser 727 1985 1 104
16. K.J. Livak Allelic discrimination using fluorogenic probes and the 5′ nuclease assay Genet Anal 14 1999 143 149
17. M. Rossouw, H.J. Nel, G.S. Cooke, P.D. van Helden, and E.G. Hoal Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene Lancet 361 2003 1871 1872
18. A. Schömig, A. Kastrati, and S. Elezi Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement Circulation 96 1997 3880 3887
19. A. Kastrati, A. Schömig, S. Elezi, H. Schühlen, M. Wilhelm, and J. Dirschinger Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions Circulation 97 1998 2396 2401
20. A. Kastrati, A. Schömig, and M. Seyfarth PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement Circulation 99 1999 1005 1010
21. A. Kastrati, W. Koch, and P.B. Berger Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting J Am Coll Cardiol 36 2000 2168 2173
22. C. Amant, C. Bauters, and J.C. Bodart D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting Circulation 96 1997 56 60
23. F. Ribichini, G. Steffenino, and A. Dellavalle Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis Circulation 97 1998 147 154
24. W. Koch, A. Kastrati, J. Mehilli, C. Böttiger, N. von Beckerath, and A. Schömig Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement Circulation 102 2000 197 202
25. E. Jouanguy, S. Dupuis, and A. Pallier In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma J Clin Invest 105 2000 1429 1436